Canature Health Technology Group Co. Ltd. said its second-quarter normalized net income came to 5 fen per share, an increase of 27.2% from 4 fen per share in the year-earlier period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was 19.6 million yuan, a gain of 26.3% from 15.5 million yuan in the prior-year period.

The normalized profit margin dropped to 12.7% from 13.8% in the year-earlier period.

Total revenue rose 39.8% on an annual basis to 157.3 million yuan from 112.5 million yuan, and total operating expenses grew 48.5% from the prior-year period to 135.3 million yuan from 91.1 million yuan.

Reported net income grew 19.3% on an annual basis to 24.8 million yuan, or 6 fen per share, from 20.8 million yuan, or 5 fen per share.

As of Aug. 15, US$1 was equivalent to 6.64 yuan.